NCT01341834 2018-04-24
Safety and Tolerability Study of RAD001 and LBH589 in All Solid Tumors With Enrichment for EBV Driven Tumors
National Cancer Centre, Singapore
Phase 1 Unknown
Clinical Trials
6 trialsNCT02616848 2015-11-30
Safety and Tolerability of Everolimus in Combination With Eribulin in Triple-negative Breast Cancers
Istituti Ospitalieri di Cremona
Phase 1 Unknown
NCT00544999 2013-09-17
Everolimus, Cytarabine, and Daunorubicin in Treating Patients With Relapsed Acute Myeloid Leukemia
National Cancer Institute (NCI)
Phase 1 Unknown
NCT01932177 2013-08-30
EVESOR
Hospices Civils de Lyon
Phase 1 Unknown
NCT00636922 2013-02-15
Everolimus (RAD001) in Elderly Patients With Acute Myeloid Leukemia
Bayside Health
Phase 1 Unknown
NCT01148628 2011-09-13
Dose-finding Study of CAELYXTM and RAD001 in Patients With Advanced Solid Tumors
Southern Europe New Drug Organization
Phase 1 Unknown